DUBLIN--(BUSINESS WIRE)--The "Single-Cell Analysis - Global Market Outlook (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Global Single-Cell Analysis Market accounted for $1.46 billion in 2016 and is expected to reach $5.08 billion by 2023 with a CAGR of 19.5%.
Factors such as growing occurrence of chronic and infectious disorder, increasing implementation of single cell analysis devices and rising government funding for cell-based research are propelling the growth of the market. However, high initial investment is hampering the market. Development in stem cell research and amalgamation of microfluidics in single-cell analysis provides ample opportunities for the market growth.
North America is anticipated to account for the biggest market share because of increase in government support for R&D and establishment of pharmaceutical and biotechnology companies. APAC is expected to grow at the highest CAGR during the forecast period owing to its increasing healthcare expenditure and rising demand for genetic analysis.
- Animal Cells
- Human Cells
- Microbial Cells
- Next-Generation Sequencing
- Flow Cytometry
- Mass Spectrometry
- Polymerase Chain Reaction
- Other Techniques
- Biotechnology and Pharmaceutical Companies
- Cell Banks and IVF Centers
- Academic & Research Laboratories
- Hospitals and Diagnostic Laboratories
- Medical Applications
- Research Applications
Key Topics Covered
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Single-Cell Analysis Market, By Cell Type
6 Global Single-Cell Analysis Market, By Product
7 Global Single-Cell Analysis Market, By Technique
8 Global Single-Cell Analysis Market, By End-User
9 Global Single-Cell Analysis Market, By Application
10 Global Single-Cell Analysis Market, By Geography
11 Key Developments
12 Company Profiling
- Thermo Fisher Scientific, Inc.
- Beckman Coulter, Inc.
- Qiagen N.V.
- GE Healthcare
- Fluidigm Corporation
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Agilent Technologies
- Becton, Dickinson and Company
- WaferGen Bio-systems, Inc.
- Eppendorf AG
- NuGEN Technologies, Inc.
- 10x Genomics
- Johnson & Johnson
For more information about this report visit https://www.researchandmarkets.com/research/fglqmx/global_5_08bn?w=4